Synapse

← Sripal Bangalore

Papers by Sripal Bangalore

Page 5 · newest first

  1. Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney DiseaseNew England Journal of Medicine · 2020
  2. Management of Coronary Disease in Patients with Advanced Kidney DiseaseNew England Journal of Medicine · 2020
  3. Health-Status Outcomes with Invasive or Conservative Care in Coronary DiseaseNew England Journal of Medicine · 2020
  4. Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval StudiesJournal of the American Heart Association · 2020
  5. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding RiskCirculation · 2020
  6. The muddy waters of the J-curve and coronary revascularizationEuropean Heart Journal · 2020
  7. Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMICritical Pathways in Cardiology A Journal of Evidence-Based Medicine · 2020
  8. Cardiovascular Risk Factors: It's Time to Focus on Variability!Journal of Lipid and Atherosclerosis · 2020
  9. The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart AllianceCJC Open · 2019
  10. Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States–based retrospective claims database analysisJournal of Medical Economics · 2019
  11. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta‐analysisCatheterization and Cardiovascular Interventions · 2019
  12. Chronic Kidney Disease and Coronary Artery DiseaseJournal of the American College of Cardiology · 2019
  13. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International · 2019
  14. Response to “The Effect of Arteriovenous Fistula on Hard Endpoints Should be Observed Prospectively in Both CKD and Non-CKD Patients”American Journal of Hypertension · 2019
  15. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO TrialCirculation · 2019
  16. Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategiesNephrology Dialysis Transplantation · 2019
  17. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical TrialJAMA Cardiology · 2019
  18. Stable coronary artery diseaseJournal of Hypertension · 2019
  19. The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting StentsCirculation · 2019
  20. Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trialEuroIntervention · 2018
  21. Identification of gene expression profiles in myocardial infarction: a systematic review and meta-analysisBMC Medical Genomics · 2018
  22. In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United StatesCardiorenal Medicine · 2018
  23. Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes MellitusCirculation Cardiovascular Quality and Outcomes · 2018
  24. Fifteen‐Year Trends in Management and Outcomes of Non–ST‐Segment–Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000–2014Journal of the American Heart Association · 2018
  25. Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on DialysisCardiology in Review · 2018
  26. Perioperative cardiovascular outcomes of non-cardiac solid organ transplant surgeryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2018
  27. Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery DiseaseCirculation · 2018
  28. Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysisEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2018
  29. Cardiac rehabilitation fitness changes and subsequent survivalEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2018
  30. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet TherapyCirculation Cardiovascular Interventions · 2018
  31. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgeryHeart · 2018
  32. Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?Journal of Thoracic Disease · 2018
  33. Paclitaxel-eluting stents versus everolimus-eluting coronary stents in a diabetic population: two-year follow-up of the TUXEDO-India trialEuroIntervention · 2017
  34. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non–ST-Segment–Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United StatesCirculation Cardiovascular Quality and Outcomes · 2017
  35. Diabetes and Hypertension: A Position Statement by the American Diabetes AssociationDiabetes Care · 2017
  36. Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta‐analysisLe Monde diplomatique en español · 2017
  37. Blood pressure control and mortality in US‐ and foreign‐born blacks in New York CityJournal of Clinical Hypertension · 2017
  38. Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial InfarctionCirculation · 2017
  39. Blood pressure and in-hospital outcomes in patients presenting with ischaemic strokeEuropean Heart Journal · 2017
  40. Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care UtilizationJournal of Managed Care & Specialty Pharmacy · 2017
  41. PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trialsJournal of Thoracic Disease · 2017
  42. Body-Weight Fluctuations and Outcomes in Coronary DiseaseNew England Journal of Medicine · 2017
  43. Management of hypertension in 2017Current Opinion in Cardiology · 2017
  44. A randomized comparison of modified subcutaneous “Z”‐stitch versus manual compression to achieve hemostasis after large caliber femoral venous sheath removalCatheterization and Cardiovascular Interventions · 2017
  45. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trialsBMJ · 2017
  46. Impact of Sex and Contact‐to‐Device Time on Clinical Outcomes in Acute ST‐Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data RegistrySHILAP Revista de lepidopterología · 2017
  47. Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac SurgeryJAMA Cardiology · 2016
  48. Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantationMedicine · 2016
  49. Long‐term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta‐analysisClinical Cardiology · 2016
  50. [OP.LB01.02] Optimal Systolic Blood Pressure Target After Sprint Insights From a Network Meta-Analysis of Randomized TrialsJournal of Hypertension · 2016